Clinical Study

Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study

Table 1

Demographic and clinical data stratified according to the use of tinzaparin and unfractionated heparin.

VariablesAll
()
UFH
()
Tinzaparin
()
value

Age (y)65.0 ± 13.265.4 ± 13.262.0 ± 13.00.95
Male (%)210 (48.4%)192 (49.7%)18 (37.5%)0.11
Body mass index (kg/m2)22.6 ± 3.722.5 ± 3.723.0 ± 3.80.399
HD duration (months)93.0 ± 68.888.1 ± 67.4133 ± 66.7<0.001
Artificial kidney 0.491
 Polysulfone (%)267 (61.5%)234 (60.6%)33 (68.7%)
 PMMA (%)121 (27.9%)111 (28.7%)10 (20.8%)
 Cellulose citrate (%)46 (10.6%)41 (10.6%)5 (10.4%)
Diabetes mellitus (%)177 (40.8%)163 (42.2%)14 (29.1%)0.082
SBP (mmHg)142.8 ± 25.9142.8 ± 26.0142.9 ± 24.50.984
DBP (mmHg)80.9 ± 62.681.2 ± 66.178.38 ± 16.90.770
Lipid-lowering agent (%)68 (15.7%)58 (15%)10 (20.8%)0.290
Kt/V1.39 ± 0.191.38 ± 0.21.4 ± 0.20.060
iPTH (pg/mL)261 ± 304249± 307341 ± 2600.053
Hemoglobin (g/dL)10.3 ± 1.210.3 ± 1.310.5 ± 1.30.212
Albumin (g/dL)4.2 ± 0.44.2 ± 0.44.2 ± 0.40.353
AST (IU/L)20.1 ± 23.320.5 ± 24.617.2 ± 5.80.357
ALT (IU/L)21.2 ± 31.021.5 ± 32.718.9 ± 9.80.584
Iron (μg/dL)65.3 ± 23.565.6 ± 23.358.4 ± 17.90.057
Ferritin (μg/dL)602 ± 468621 ± 500471 ± 2370.044
TIBC (μg/dL)211 ± 41210 ± 41217 ± 400.219
Total-bilirubin (mg/dL)0.32 ± 0.20.33 ± 0.260.27 ± 0.09<0.001
Alk-p (mg/dL)92.8 ± 71.493.4 ± 74.188.3 ± 43.60.640
Uric acid (mg/dL)6.9 ± 1.36.8 ± 1.37.0 ± 1.20.274
Sodium (meq/L)139.3 ± 3.2139.1 ± 3.3140.3 ± 2.80.017
Potassium (meq/L)4.6 ± 0.74.6 ± 0.74.7 ± 0.60.515
Ionized calcium (mg/dL)4.9 ± 0.54.9 ± 0.55.1 ± 0.50.023
Phosphate (mg/dL)5.1 ± 1.45.1 ± 1.45.23 ± 1.10.459

Values for continuous variables are expressed as mean ± standard deviation; values for categorical variables are given as a number (percentage). UFH: unfractionated heparin; HD: hemodialysis; PMMA: polymethylmethacrylate; SBP: systolic blood pressure; DBP: diastolic blood pressure; iPTH: intact parathyroid hormone; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TIBC: total iron-binding capacity; Alk-p: alkaline phosphatase.